←Back to Expert Scholars
Translational Medicine / 转化医学Pediatric Sarcoma, IGF1R
Lee Helman
MD
🏢Children's Hospital Los Angeles🌐USA
Senior Scientific Advisor
100
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Lee Helman is a foundational figure in pediatric sarcoma research who defined the role of IGF1R pathway in rhabdomyosarcoma and Ewing sarcoma. His NCI laboratory advanced translational studies of pediatric solid tumors. He has mentored many pediatric sarcoma investigators and shaped national drug development.
Share:
🧪Research Fields 研究领域
pediatric sarcoma
rhabdomyosarcoma
Ewing sarcoma
IGF1R pathway
drug development
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Lee Helman 的研究动态
Follow Lee Helman's research updates
留下邮箱，当我们发布与 Lee Helman（Children's Hospital Los Angeles）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment